Merlin Nexus
Merlin Nexus, based in New York, is a company focused on crossover private equity investing in the life sciences industry.
Business Model:
Revenue: $15.2M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Merlin Nexus Information
Geographic Data
Address: 230 Park Ave
City: New York
State: NY
Zip: 10169
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Merlin Nexus, based in New York, is a company focused on crossover private equity investing in the life sciences industry. Merlin Nexus invests globally in private and public healthcare companies. With its first fund launched in 2001 by Dominique Sémon, Merlin Nexus now has several crossover private equity funds and a public-only fund, with commitments totaling over $175 million. Currently, the Merlin Nexus team consists of 5 investment professionals. Their varied healthcare backgrounds provide broad industry knowledge spanning later-stage biotechnology, specialty pharmaceuticals and medical devices. It has later-stage investment focus as compared to traditional venture capital firms and invests opportunistically and selectively. The company&s;s investor base consists of financial institutions, funds of funds, family offices and high net worth individuals.
Contact Phone:
+16462275200
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2007 | Xencor | Series E | 15M |
| 12/2013 | Stem Cell Therapeutics | Post-IPO Equity | 0 |
| 10/2008 | Micromet | Post-IPO Equity | 0 |
| 1/2016 | Zymeworks | Series A | 0 |
| 4/2009 | Sunesis Pharmaceuticals | Post-IPO Equity | 0 |
| 9/2014 | Adaptimmune | Series A | 0 |
| 5/2011 | WaferGen Biosystems | Post-IPO Equity | 0 |
| 1/2016 | Zymeworks | Series A | 0 |
| 9/2014 | Adaptimmune | Series A | 0 |
| 12/2013 | Stem Cell Therapeutics | Post-IPO Equity | 0 |
| 5/2011 | WaferGen Biosystems | Post-IPO Equity | 0 |
| 4/2009 | Sunesis Pharmaceuticals | Post-IPO Equity | 0 |
| 10/2008 | Micromet | Post-IPO Equity | 0 |
| 10/2007 | Xencor | Series E | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
